GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.550
-0.030 (-1.16%)
At close: Feb 27, 2026, 4:00 PM EST
2.470
-0.080 (-3.14%)
After-hours: Feb 27, 2026, 6:58 PM EST
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.68 million as of February 27, 2026. Its market cap has decreased by -25.00% in one year.
Market Cap
3.68M
Enterprise Value
-4.47M
1-Year Change
-25.00%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $3.68M, a decrease of -85.43%. That is a compound annual growth rate of -49.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.68M | 47.52% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Decoy Therapeutics | 4.36M |
| Galmed Pharmaceuticals | 4.28M |
| GeoVax Labs | 4.20M |
| Acurx Pharmaceuticals | 4.18M |
| PMGC Holdings | 4.09M |
| Jaguar Health | 3.87M |
| Matinas BioPharma Holdings | 3.85M |
| 60 Degrees Pharmaceuticals | 3.81M |